Derivatives of 1,2,4-triazole imines acting as dual iNOS and tumor cell growth inhibitors

Christophe Guillon, Anna M. Vetrano, Jaya Saxena, Angela Hunter, Geraldine Verderone, Thomas M. Finetti, Jeffrey Wisnoski, Peter W. DeMatteo, Robert D. Rapp, Ned D. Heindel, Laurie B. Joseph, Diane E. Heck, Jeffrey D. Laskin

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

A set of 4-(R2-imino)-3-mercapto-5-(R1)-4H-1,2,4-triazoles derivatives were synthesized, characterized and evaluated for their ability to inhibit nitric oxide (NO) production in PAM212 mouse keratinocytes, which led to the discovery and the subsequent evaluation of their growth inhibitory cytotoxic potency toward that same mouse cell line together with a number of human cells lines (PC3, HT-29 and HeLa). Some limited SAR could be established for both NO production inhibition potency and growth inhibition cytotoxicity. Noticeably, the compounds designed to be nitrofurantoin mimics were the most potent anti-neoplastic agents.

Original languageEnglish (US)
Article number104128
JournalBioorganic Chemistry
Volume103
DOIs
StatePublished - Oct 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Drug Discovery
  • Organic Chemistry

Keywords

  • Anti-neoplastic agents
  • HT-29
  • HeLa
  • Nitric oxide synthase
  • Nitrofurantoin
  • Nitrofurazone
  • PAM212
  • PC3
  • Triazole
  • iNOS inhibitors

Fingerprint

Dive into the research topics of 'Derivatives of 1,2,4-triazole imines acting as dual iNOS and tumor cell growth inhibitors'. Together they form a unique fingerprint.

Cite this